SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-22-012331
Filing Date
2022-03-30
Accepted
2022-03-30 08:30:15
Documents
12
Period of Report
2022-03-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A apvo-8ka_20220329.htm   iXBRL 8-K/A 41401
  Complete submission text file 0001564590-22-012331.txt   175693

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA apvo-20220329.xsd EX-101.SCH 5733
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20220329_lab.xml EX-101.LAB 20142
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20220329_pre.xml EX-101.PRE 12052
6 EXTRACTED XBRL INSTANCE DOCUMENT apvo-8ka_20220329_htm.xml XML 4189
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37746 | Film No.: 22783324
SIC: 2834 Pharmaceutical Preparations